Aptevo Therapeutics Inc. (APVO)

CIK 1671584 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aptevo Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 20268-K0001193125-26-448714
Nov 2, 20268-K0001193125-26-442031
Oct 30, 2026424B50001193125-26-441770
Oct 26, 20268-K0001193125-26-431079
Oct 23, 20268-K0001193125-26-430419
Oct 14, 20268-K0001193125-26-421076
Sep 25, 2026S-80001193125-26-402813
Sep 24, 20268-K0001193125-26-400213
Sep 23, 20268-K0001193125-26-399545
Sep 3, 2026424B40001193125-26-381149
Sep 3, 20268-K0001193125-26-381098
Sep 2, 2026EFFECT9999999995-26-002871
Aug 31, 2026DEF 14A0001193125-26-376763
Aug 26, 2026D0001193125-26-368286
Aug 21, 2026S-10001193125-26-361103
Aug 21, 20268-K0001193125-26-361079
Aug 21, 2026PRE 14A0001193125-26-361119
Aug 14, 202610-Q0001193125-26-350559
Aug 14, 20268-K0001193125-26-350537
Aug 14, 2026SCHEDULE 13G/A0001649553-26-000098
Aug 13, 20268-K0001193125-26-349380
Aug 10, 202640001193125-26-343073
Aug 10, 202640001193125-26-343072
Aug 10, 202640001193125-26-343069
Aug 10, 202640001193125-26-343076